Table 3.
Correlation between WEM and ppVD in different groups of patients with TAO
| ppVD (%) | Before adjusting | After adjusting* | |||
|---|---|---|---|---|---|
| r | p | r | p | ||
| Whole | 52.0582 ± 2.51869 | 0.253 | 0.042 | 0.306 | 0.017 |
| S-Hemi | 52.2072 ± 2.70443 | 0.21 | 0.093 | 0.273 | 0.033 |
| I-Hemi | 51.8911 ± 2.77253 | 0.269 | 0.030 | 0.286 | 0.025 |
| NS | 46.2786 ± 4.29851 | 0.076 | 0.549 | 0.052 | 0.690 |
| NI | 46.1905 ± 4.45785 | 0.279 | 0.024 | -0.054 | 0.677 |
| IN | 51.5102 ± 4.43887 | 0.235 | 0.060 | 0.279 | 0.030 |
| IT | 56.4786 ± 4.30438 | 0.216 | 0.085 | 0.29 | 0.024 |
| TI | 6.5982 ± 378.76292 | 0.195 | 0.119 | 0.105 | 0.421 |
| TS | 10.9829 ± 379.31457 | 0.115 | 0.361 | 0.104 | 0.424 |
| ST | 53.6462 ± 3.80568 | 0.287 | 0.021 | 0.274 | 0.033 |
| SN | 50.4791 ± 4.12793 | 0.253 | 0.042 | 0.298 | 0.020 |
The p-value indicated in bold meets the threshold of 0.05
*Age, gender, AL and bIOP were used as control variables to adjust the correlation analysis
WEM whole eye movement, ppVD peripapillary vessel density, TAO thyroid-associated ophthalmopathy, NS nasal-superior, NI nasal-inferior, IN inferior-nasal, IT inferior-temporal, TI temporal-inferior, TS temporal-superior, ST superior-temporal, SN superior-nasal, AL axial length, bIOP biomechanically corrected intraocular pressure